摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-羟甲基苯甲酰胺 | 6282-02-6

中文名称
N-羟甲基苯甲酰胺
中文别名
N-(羟甲基)苯甲酰胺
英文名称
N-(hydroxymethyl)benzamide
英文别名
——
N-羟甲基苯甲酰胺化学式
CAS
6282-02-6
化学式
C8H9NO2
mdl
MFCD00014415
分子量
151.165
InChiKey
UOUBPDZUBVJZOQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    95-100 °C
  • 沸点:
    273.17°C (rough estimate)
  • 密度:
    1.2023 (rough estimate)
  • 溶解度:
    DMSO(少许)、水(少许)
  • 稳定性/保质期:

    常温常压下稳定,粉末状。

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    49.3
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S37/39
  • 危险类别码:
    R36/37/38
  • WGK Germany:
    1
  • 海关编码:
    2924299090
  • 危险性防范说明:
    P261,P301+P312,P302+P352,P304+P340,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    请将药品存放在避光、阴凉干燥的地方,并密封保存。

SDS

SDS:fdd1c54f16f457977b1648860ebc4dc7
查看
Name: N-(Hydroxymethyl)Benzamide 98% Material Safety Data Sheet
Synonym: Benzamidomethanol
CAS: 6282-02-6
Section 1 - Chemical Product MSDS Name:N-(Hydroxymethyl)Benzamide 98% Material Safety Data Sheet
Synonym:Benzamidomethanol

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
6282-02-6 N-(Hydroxymethyl)Benzamide 98% 228-495-0
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause irritation of the digestive tract. May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
Causes respiratory tract irritation. Inhalation may be fatal as a result of spasm, inflammation, edema of the larynx and bronchi, chemical pneumonitis and pulmonary edema. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 6282-02-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 94-96 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H9NO2
Molecular Weight: 151.0685

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 6282-02-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-(Hydroxymethyl)Benzamide - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 6282-02-6: 1
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 6282-02-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 6282-02-6 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

N-羟甲基苯甲酰胺

N-羟甲基苯甲酰胺是一种有机中间体,可用于实验室有机合成过程。它可以通过一步反应由苯甲酰胺和甲醛制备得到,并有文献报道可用于制备抑菌型紫外线吸收剂

制备方法

向70.0g(0.58mol)苯甲酰胺的溶液中添加40%甲醛(45.0g,0.60mol)和2.00g(14.5mmol)碳酸(70mL)溶液。将其在浴上加热,直到形成澄清溶液,然后结晶。用稀乙醇重结晶后,得到N-羟甲基苯甲酰胺(CAS号:6282-02-6),纯度为85%,为结晶固体,熔点104℃。

用途

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    外层配位化学:酰胺基铵配体作为高选择性四氯氧化锌(II)萃取剂
    摘要:
    合成了八种新的酰胺基官能化试剂L 1 –L 8,其包含原子序列R 2 N–CH 2 –NR'–CO–R”,其在质子化时形成六元螯合物,在氢原子之间形成氢键。叔铵NH +基团和酰胺氧原子。单阳离子配体LH +通过一种机制从两个含有高浓度氯离子的酸性溶液中萃取四氯化金属(II),其中两个配体同时使用N-H和H-来处理[MCl 4 ] 2-单元的“外球”。C-H氢键供体,以形成中性配合物作为在2L + 2HCl的+的MC1 2 ⇌[(LH)2 MCl 4 ]。在这些依赖于pH的平衡中,作为锌萃取剂的L 1 –L 8的强度已非常依赖于R 3- n N(CH 2 NR'COR'')n分子中的酰胺基数量,随着存在的强氢键供体数量的增加,直觉递减,并遵循单酰胺>二酰胺>三酰胺的顺序。对氯化物浓度对萃取的影响的研究表明,特别是单酰胺对[ZnCl 4 ] 2-的选择性高于对[FeCl 4 ] -的选择性和Cl
    DOI:
    10.1021/ic301691d
  • 作为产物:
    描述:
    苯甲酰胺聚合甲醛 作用下, 以84%的产率得到N-羟甲基苯甲酰胺
    参考文献:
    名称:
    Preparation of 3-chloromethyl-4-alkyl-nitrobenzene by chloromethylation
    摘要:
    一种从相应的酰胺甲基衍生物通过磷酰氯或磷酰氯和惰性溶剂制备4-烷基-3-氯甲基硝基苯衍生物的方法。这个过程还涉及到3-氯甲基-4-烷基硝基苯,它们是有用的中间体,用于制备某些取代的2,6-二硝基苯胺类芽前除草剂。
    公开号:
    US04395577A1
点击查看最新优质反应信息

文献信息

  • Synthesis and conformational analysis of dibenzodithiocin derivatives
    作者:P. Sohár、I. Kövesdi、J. Szabó、Á. Katócs、L. Fodor、E. Szücs、G. Bernáth、J. Tamás
    DOI:10.1002/mrc.1260270809
    日期:1989.8
    thyl)aroylamides (la, b) reacted with phosphoryl chloride to give not only the expected 4H‐ and 2H‐1,3‐benzothiazine derivatives (4a, b and 5a, b), but also dibenzodithiocins of new (dibenzo[d,g][1,3]dithiocins 2a, b) and known (dibenzo[b,f][1,5]dithiocins 3a, b) types. The analogous reaction of the 4‐methylaroylamide 8a furnished the 4H‐1,3‐benzothiazine 9a, the dibenzo[b, f][1,5]dithiocin derivative
    N-(3,4-二烷氧基苯甲基)芳酰胺 (la, b) 与反应不仅得到预期的 4H- 和 2H-1,3-苯并噻嗪生物 (4a, b 和 5a, b),而且得到新的 (dibenzo[d,g][1,3]dithiocins 2a, b) 和已知的 (dibenzo[b,f][1,5]dithiocins 3a, b) 类型。4-甲基芳酰胺8a的类似反应得到4H-1,3-苯并噻嗪9a、二苯并[b, f][1,5]二辛衍生物10a和苄腈。相比之下,8b(8a 的类似物)仅提供苄腈和双(4-氯苯基巯基)甲烷(11)。新化合物的结构通过 IR、1H 和 13C NMR 和(部分)通过质谱法确认。温度相关的 1H NMR 研究用于 2a 及其二砜 6a 的构象分析;
  • A convenient and clean synthesis of methylenebisamides and carbinolamides over zeolites in aqueous media
    作者:Naresh Mameda、Mahender Reddy Marri、Swamy Peraka、Arun Kumar Macharla、Srujana Kodumuri、Durgaiah Chevella、Gutta Naresh、Narender Nama
    DOI:10.1016/j.catcom.2014.12.006
    日期:2015.2
    A simple, efficient and environmentally benign protocol for the synthesis of methylenebisamides and carbinolamides in high yields from aromatic amides and formaldehyde in the presence of heterogeneous catalysts (Hβ and NaY zeolites) using water as a solvent is demonstrated. Moreover, the catalyst is recyclable and can be reused without significant loss in its catalytic activity.
    为溶剂的非均相催化剂(Hβ和NaY沸石)存在下,从芳族酰胺和甲醛以高收率合成亚甲基双酰胺和甲醇酰胺的简单,有效和环境友好的方案得到了证明。此外,该催化剂是可回收的,并且可以在不显着损失其催化活性的情况下被重复使用。
  • Atom-Economical and Tandem Conversion of Nitriles to <i>N</i>-Methylated Amides Using Methanol and Water
    作者:Bhaskar Paul、Milan Maji、Sabuj Kundu
    DOI:10.1021/acscatal.9b03916
    日期:2019.11.1
    A cobalt complex catalyzed tandem conversion of nitrile to N-methylated amide is described using a methanol and water mixture. Using this protocol, several nitriles were directly and efficiently converted to the desired N-methylated amides. Kinetic experiments using H2O18 and CD3OD suggested that water and methanol were the source of the oxygen atom and methyl group, respectively, in the final N-methylated
    描述了使用甲醇的混合物的络合物催化的腈串联转化为N-甲基化酰胺。使用该方案,将几个腈直接有效地转化为所需的N-甲基化酰胺。使用H 2 O 18和CD 3 OD进行的动力学实验表明,甲醇分别是最终N中氧原子和甲基的来源。-甲基化酰胺。重要的是,控制实验实现了活性Co(I)–H物种参与该转化的过程。动力学同位素效应(KIE)研究表明,甲醇C–H键的活化是动力学上重要的一步。哈米特图证实了电子不足的腈的反应更快。此外,计算研究支持了从腈形成N-甲基化酰胺的可能途径。
  • Depsipeptides and Their Therapeutic Use
    申请人:Shuttleworth Stephen Joseph
    公开号:US20110112090A1
    公开(公告)日:2011-05-12
    A Compound of structure (IX) or (X) or a pharmaceutically acceptable salt thereof, wherein: X is —C(═O)N(R 10 )— or —CH(OPr 3 )—; R 7 , R 9 and R 10 are the same or different and represent hydrogen or an amino acid side chain moiety from either a natural or an unnatural amino acid; Pr 1 and Pr 2 are the same or different and represent hydrogen or a thiol protecting group; Pr 3 is hydrogen or an alcohol protecting group; R 1 , R 2 , R 5 and R 6 are the same or different and represent hydrogen or an amino acid side chain moiety from either a natural or an unnatural amino acid, or R 1 and R 2 and/or R 5 and R 6 , taken together with the carbon atom to which they are attached, form a spirocyclic moiety, with the proviso that: each of R 1 and R 2 is not hydrogen, or each of R 5 and R 6 is not hydrogen.
    一种结构化合物(IX)或(X)或其药学上可接受的盐,其中:X为—C(═O)N(R10)—或—CH(OPr3)—;R7、R9和R10相同或不同,代表氢或来自天然或非天然氨基酸氨基酸侧链基团;Pr1和Pr2相同或不同,代表氢或巯基保护基团;Pr3为氢或醇保护基团;R1、R2、R5和R6相同或不同,代表氢或来自天然或非天然氨基酸氨基酸侧链基团,或R1和R2和/或R5和R6,与它们连接的碳原子一起形成螺环基团,条件是:R1和R2中的每一个都不是氢,或R5和R6中的每一个都不是氢。
  • Tandem Transformation of Aldoximes to N‐Methylated Amides Using Methanol
    作者:Bhaskar Paul、Milan Maji、Dibyajyoti Panja、Sabuj Kundu
    DOI:10.1002/adsc.201900962
    日期:2019.12.3
    Tandem conversion of aldoximes to N‐methylated amides with methanol in presence of a single Ru(II) catalyst is accomplished through the Ru(II)‐mediated rearrangement followed by the reductive N‐methylation. Employing this protocol, several aldoximes were directly transformed to the N‐methylated amides using methanol. Kinetic experiments with H218O advocated that the aldoxime is acted as the nucleophile
    在单一Ru(II)催化剂存在下,用甲醇将醛串联转化为N-甲基化酰胺是通过Ru(II)介导的重排,然后进行还原性N-甲基化来实现的。采用该方案,使用甲醇将几种醛直接转化为N-甲基化酰胺。用H 2 18 O进行的动力学实验表明,在醛到酰胺的重排过程中,醛是亲核试剂。通过动力学研究实现了腈中间体在该转化过程中的参与。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫